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Introduction
The capacity for white adipose tissue to store fat is a function of the repertoire of fat-specific genes that provides those enzymes and proteins required for the transport and conversion of energy substrates into fat and others which enable it to be mobilized for the energy needs of the body (1) . This function to store energy in its most concentrated form makes the white adipocyte one of the most energetically efficient cells in the body. However, there is another adipocyte, the brown adipocyte, that expresses a similar set of fat-specific genes plus a few others that enable it to produce heat as its major function. The mechanism of thermogenesis in brown adipocytes is based on the mitochondrial uncoupling protein (UCP),' a proton channel protein in the inner mitochondrial membrane which converts the electrochemical potential of the mitochondria into heat instead of ATP (2) . Reflecting this novel physiological uncoupling of oxidative phosphorylation, brown adipose tissue mitochondria are endowed with a high oxidative capacity, a high content of cytochrome oxidase, but a low content of ATP synthetase (3, 4) Accordingly, two features distinguish white and brown adipocytes, one qualitative, the expression of Ucp, and the other quantitative, the high content of mitochondria with their unique stoichiometry of protein complexes in the inner membrane.
The idea that Ucp might be involved in regulating energy balance and that abnormalities in brown fat might result in obesity was first proposed by Rothwell and Stock (5) . In support of the idea, it was pointed out that genetically obese mice are not able to withstand exposure to cold and therefore have defective brown fat thermogenesis (6, 7) The defective thermogenesis would underlie the obesity. In addition to an apparent functional defect in genetically obese mice, activation of thermogenesis in brown fat by diet also suggests a causal link between brown fat metabolism and energy balance (for a review see 8) . Nevertheless, the complexity due to (1) the relationship of energy balance to the action of the sympathetic nervous system, and (2) the affects of the progression of obesity on the action of the sympathetic nervous system and energy metabolism has precluded our ability to establish a direct causal relationship between obesity and brown fat thermogenesis. Yet the idea that perturbations in a system, the function of which is known to only be heat production, should affect obesity is inherently appealing. The recent demonstration that the ablation of brown fat in mice, caused by a transgene of the Ucp promoter driving expression of the diptheria toxin gene, results in reduced brown fat thermogenesis and obesity has provided the first direct evidence for a causal relationship between brown fat thermogenesis and obesity (9) Conversely, the reciprocal experiment to overexpress Ucp in white adipocytes would test the idea that enhanced nonshivering thermogenesis can reduce obesity. Thus, we have constructed transgenic mice in which the Ucp gene is driven by the fat-specific aP2 promoter to achieve enhanced expression in both brown and white fat (10) These mice show a marked reduction in adiposity and, in some instances, a resistance to obesity. exon 1 to remove the Ucp 5' flanking region. A Notd linker was added to the BglI site ( 11) , (Fig. 1) 3' orientations were selected. A 13.5-Kb Sacdl-XhoI fragment carrying the aP2 regulatory region and the Ucp gene was isolated by preparative electrophoresis in an agarose gel and purified using a Gene Clean Kit (BIO 101, Inc., Vista, CA). Microinjection into C57BL/6J mouse embryoes was carried out as previously described (12) .
Transgenic founders were identified and gene copy number determined by Southern blot analysis of tail DNA cut with BglIl and probed with a 1.4 kb HindllI-KpnI fragment labelled with random primers ( 13 ) . Subsequently, mice carrying the transgene were identified by PCR carried out with the primer pair Ucp-6 (CAATCTGGGCTTAACGGG-TCC) and Ucp-180 (CTGAAGACAACAGTGGCACTG) for the endogenous Ucp gene and aP2-83 (GAAATGATGTGGCCCCCATTG) and Ucp-180 for the transgene.
RNA analysis. Total RNA was isolated using guanidinium thiocyanate as described (14) . Ucp mRNA was analyzed by Northern blot analysis (15) ; however, in order to distinguish between the endogenous gene transcript and the transgene transcript a primer extension assay was developed. Priming the reverse transcriptase reaction with CCT-GAAGACAACAGTGGCACTGTTGCCTGATGCGGGCACGAA-GCC yields a 132 base transcript from the aP2-Ucp transgene and a 180 base transcript from the endogenous Ucp gene (see Fig. 2 The transcription of the aP2-Ucp transgene initiates from the aP2 gene transcription start site within the aP2-Ucp promoter. The tissues analyzed were brown fat (B), liver (L) and white fat (w). Details of the assay are given in Methods. A primer extended product is only detected in the brown fat of tissues from nontransgenic mice. In transgenic mice the brown fat has two products, the endogenous product of 180 bp and the trangene product at 132 bp; no products are detected in the liver and a weak signal is detected in the white fat. enabled us to determine the relative levels of endogenous and transgene expression. In the brown fat, the transgenic Ucp transcript was much more abundantly expressed than the endogenous gene transcript. Only the transgenic transcript was detected in white fat depots with similar levels of expression found in subcutaneous and peritoneal and in males and females (Fig. 2) .
To evaluate the effects of changes in thermal requirements on mRNA production, RNA was isloated from the brown and white fat of mice maintained at 40, 200, and 280C (Fig. 3) . In the brown fat of the transgenic mice, increases in ambient temperature resulted in the expected progressive decrease in the amount of transcript derived from the endogenous gene, while the transcript derived from the transgene was unaffected by the change in temperature. Similarly, the amount of mRNA produced in the white fat depots was unaffected by temperature.
The amount of UCP present in brown and white fat was determined by immunoblot analysis (Fig. 4) detected in the white fat of transgenic mice and in the brown fat of both transgenic and control mice, but not in other tissues. Fractionation of the homogenates from the UCP containing tissues by differential centrifugation indicated that the UCP was associated with the mitochondrial fraction and that there was no UCP in the cytosol (data not shown). In brown fat, the level of UCP in the transgenic mice was virtually identical to that observed in control mice. Therefore, the additional capacity to synthesize UCP in brown fat due to the presence of the transgene did not in fact result in more UCP. The lower levels of Ucp transcript due to the reduced expression of endogenous Ucp gene did not result in lower levels of the protein, thus providing evidence that the regulation of UCP levels in brown fat adjusts to the synthesis of functionally active UCP from constitutively expressed aP2-Ucp. The concentration of UCP in the white fat of transgenic mice on the C57BL/6J background is much lower than in brown fat (0.5 Mg UCP/mg protein in white fat compared to 50 ttg UCP/mg protein in brown fat).
Assuming that the total amount of white fat dissected from the various fat depots represents roughly one-half of the total white adipose tissue, the total content of UCP in white fat does not exceed 2% of the UCP of the interscapular brown fat (Table I) Fig. 6 . In contrast, the peritoneal fat, specifically the gonadal fat of the female, had increased in weight almost in proportion to the reduction in weight of subcutaneous fat (Fig. 6) . These results are illustrated in Fig. 7 where the total body weight is correlated to the gonadal fat weight. It is apparent from this data that at any given body weight the ovarian fat pads are markedly larger in the transgenic mice. At six months of age, the effects of the aP2-Ucp transgene on fat deposition are not readily detectable except on the female femoral fat pad; however, at one year of age striking differences are apparent in both sexes (Table II) . In the transgenic mice significant reductions are found in total body weight and the weights of the femoral and mesenteric fat pads of both sexes and the renal fat pad was also reduced in male transgenic mice. In contrast, the gonadal fat continued to be heavier in in females and was not significantly changed in males. No differences in the weights of interscapular brown fat or the liver were detected at any age. Thus the transgene has differential effects on subcutaneous fat and gonadal fat depots that do not become apparent until the mouse reaches midlife. It is should also be pointed out that these nontransgenic, control C57BL/6J male mice, some weighing in excess on 50 grams, are obese. Since no reductions in total body weight were initially detected in young mice carrying the transgene on the C57BL/6J background strain, the aP2-Ucp transgenic mice were crossed to C57BL/6J-A'Y/+ genetically obese mice in order to determine whether the transgene could alter the development of obesity. The effects of the transgene on reducing body weight in young AY mice (7 wk of age) were modest, but significant, causing a 15% reduction. However, with increasing age the differences Body Weight (gm) Figure 6 . (Table I ), no significant difference was observed between the nontransgenic and aP2-Ucp transgenic mice, similar to expression on C57BL/6J mice. However, the concentrations and total UCP content in brown fat of A'Y mice was 1.5-2.0-fold lower than that determined in non-A y C57BL/6J mice. In contrast, the UCP content of the white fat depots (1. The aP2-Ucp gene caused significant differences in the body weight (P < 0.01) of AU3/+ females (*) and males (*) but not in the +/+ mice of either sex.
present in interscapular brown fat. Accordingly, the amount of UCP in the white fat of transgenic mice is several fold higher in the presence of genetically determined obesity. Cell numbers and fat morphology. To determine whether fat cell size or number accounted for the increase in gonadal fat pad weight, fat tissue was dissociated with collagenase and the adipocytes were separated from the stromal vascular fraction by centrifugation. Cells were floated on embryological depression slides and photographed in the presence of an ocular micrometer (21) . Enlarged prints of the fields were produced and the sizes of cells were determined. This method established that the adipocytes isolated from the aP2-Ucp transgenic mice were much smaller than those from nontransgenic mice; however most striking were the bizarre shapes of adipocytes isolated from the aP2-Ucp transgenic mice (data not shown). These cells were also fragile as evidenced by the frequency with which they ruptured as they were viewed under the microscope. The attempt to determine cell numbers by cell isolation techniques was not successful; however, it provided preliminary evidence that the adipocytes from the transgenic mice were different than those from the nontransgenic mice and semiquantitative evidence that more cells were present in the gonadal fat of aP2-Ucp transgenic mice.
Histological analysis of paraffin-embedded fat tissue stained with hematoxylin and eosin provided direct evidence of the change in tissue morphology. Photomicrographs of sections from the ovarian and femoral fat pads of AY transgenic and nontransgenic mice are shown in Fig. 8 . Both fat pads in the nontransgenic mice (Fig. 8, A and B) show a uniform field of adipocytes with a large monocular lipid droplet surrounded by a thin ring of cytpolasm. In contrast, the ovarian fat pads from the transgenic mouse (Fig. 8 C) show a heterogeneous field composed of cells with the typical adipocyte morphology, but variable in size, interspersed with large numbers of a small lipid-depleted cell. These small cells appear as the animals begin to age and their numbers increase during this period (Fig. 9) . They are also more abundant in transgenic mice which are susceptible to obesity. For example, only small numbers are detected in transgenic mice on the normal C57BL/6J background (Fig. 10 B) as compared with the large numbers in the gonadal pad from obese A Y aP2-Ucp transgneic mice (Fig. 8,  9 , and 10 C). Only a few small cells could be detected in the femoral fat pads, but this tissue, which is greatly reduced in the transgenic mice, was principally characterized by the large blood vessels coursing throughout the tissue (Fig. 8) . The reduction in the weight of the femoral fat pad is the earliest known phenotypic difference to result from the presence of the aP2-Ucp transgene.
In some animals the number of these cells exceeded the number of large, fully differentiated white adipocytes. To provide an estimate of the increase in cell number represented by the adipocyte derivatives, the DNA content of the gonadal fat pad was determined. No significant changes in DNA content were found in transgenic vs nontransgenic mice on the C57BL/ 6J background (-0.9 jzg DNA/gm of tissue); however, A" mice carrying the transgene had a highly significant 5-10-fold increase in DNA content (4.6-8.4 ,ug DNA/gm of tissue). Based upon the histology of the tissues which show few of the small cells in fat pads of transgenic mice on the normal C57BL/ 6J background and a lack of a differences in DNA content, it is probable the 5-10-fold increase in DNA content of the fat pads from transgenic A ' mice is due to the expansion of the small cell population in the tissue.
The appearance within fat of the small cells described above is not a common occurrence; in fact we were unable to find any references documenting a similar finding. To characterize this cell type, tissue sections were analyzed by immunohistochemistry using antibodies specific for UCP, the aP2 protein and ly 5.2, an antigen specific for hemopoietically-derived cells from C57BL/6J mice (22) . The small cells reacted positively with both anti-UCP and anti-aP2 antibodies suggesting that they are adipocyte derivatives, even though they do not accumulate lipids. We shall refer to these cells as adipocyte derivatives. The absence of a reaction with anti-ly 5.2 (data not shown) underscores the fact that these cells are distinct from the small number of lymphocytes that are occasionally present in the ovarian fat pads of the transgenic mice, particularly around the blood vesicles.
On the basis of histological exmination, there appeared to be more adipocyte derivatives in female than in male gonadal fat. The subcutaneous femoral fat depots also contain adipoblasts but in small numbers; however, the most striking feature of this tissue was the presence of large areas composed of a fibroblastic-like cell devoid of lipid stores.
Discussion
Our experiments demonstrate that the enhanced expression of Ucp can reduce obesity. To A B C D Figure 10 . Immunohistology of (A) brown fat from a C57BL/6J female; (B) ovarian fat from an aP2-Ucp transgenic C57BL/6J female mouse at sity and age play in determining the quantitative characteristics of the phenotype. Before 3 mo of age it is difficult to detect any effect of the transgene on C57BL/6J mice which do not carry the A v gene. Mice older than 3 mo show reduced femoral fat; however, this difference cannot be detected in body weight because the gonadal fat is concurrently increasing in weight. By one year of age an effect of the transgene on reductions in overall body weight and on other fat depots become detectable. At this age C57BL/6J mice become obese with the consequence that the effects of the transgene are most evident in the context of obesity. On the other hand, if the transgenic mice also carry the A Y gene which normally induces obesity, a striking difference between the transgenic and nontransgenic animal was found at an earlier age. These differences include changes in (1) the weight of the fat pads; (2) overall body weight; (3) the expression of Ucp from both the transgene in the white fat and the endogenous gene in the brown fat; and (4) the appearance of a novel adipocyte derivative in the peritoneal fat depots of the A ' mice. The results indicate a synergy between the thermogenic capacity of the transgene and the obesity which is augmented by age and the A ' gene. The sex of the mice appears to be another independent factor which influences the phenotypes in a manner that is not understood.
We have no direct evidence that the UCP derived from the transgene is thermogenically functional and responsible for the reduction in fat. The indirect evidence is based on the strong down regulation of the endogeneous Ucp gene in brown fat in the presence of this transgene provides evidence that the constitutively active aP2-Ucp transgene must be functional otherwise a down regulation of the endogenous gene should not occur. Himms-Hagen has emphasized the ability of nonshivering thermogenesis to function as a energy buffer modulating its level of expression in response to level of heat that may be produced in the animal as a consequence of environmental temperature, fever and exercise (7) . That endogenous Ucp expression is reduced in relationship to the obesity stress suggests a similar mechanism occurrs in the aP2-Ucp transgenic mice. Although the increase in UCP has been detected only in the white fat compartment, one cannot be certain that this is the basis for the fat reduction. The consequences of constitutive Ucp expression in brown fat on thermogenesis needs to be evaluated with another kind of transgenic mouse.
The ability of UCP to function ectopically is not surprising, since it has been shown that mammalian UCP reconstituted into Chinese hamster ovary cells (24) or yeast mitochondria (25) is functional. The important point is that only very low levels of UCP in the white fat may be sufficient to affect obesity and that a broader spectrum of tissues and cell types may be capable of harboring a UCP based thermogenic system that could control obesity. It has been demonstrated that proton leakage across the inner mitochondrial membrane of hepatocytes can contribute significantly to resting oxygen consumption and therefore heat production (26). The molecular mechanisms underlying this proton leakage are not well understood. However, it is plausible that the UCP derived from the transgene increases proton leakage in the white fat mitochondrial to generate sufficient heat to reduce fat stores in the animals of this study. It also follows that mechanisms to increase mitochondrial proton leakage, even independent of UCP, could be effective in altering energy balance.
The earliest and largest difference in fat accumulation occurred in the reduction of the femoral/inguinal fat pad. With the exception of interscapular brown fat, which did not change in size in the transgenic mice, the subcutaneous fat depots were all reduced; but unlike the femoral-inguinal fat, the other depots of subcutaneous fat are difficult to dissect cleanly and reproducibly from the mouse. Importantly, the level of expression of the aP2-Ucp transgene in the femoral fat was less not higher than that measured in gonadal fat where there was a increase in the weight of the tissue. This suggests that the changes in regional fat metabolism in this animal is not determined by a mechanism autonomous for each fat pad, rather alterations and adjustments in the equilibrium of energy metabolism occur at the systemic level. Why the subcutaneous fat is privileged to be the first to reduce fat stores is an important and unresolved question.
The appearance of a cell in the gonadal fat which is positive for UCP and the aP2 protein suggests that the cell is derived from an adipocyte though it lacks the monolocular or multilocular lipid vesicles characteristic of white fat or brown fat. Since all of the Ucp mRNA is derived from the aP2-Ucp in the white fat transgene and there is no trace of the endogenous Ucp mRNA (see Fig. 2 and 3) , the cells in the gonadal fat which are positive for Ucp expression have not arisen de novo from a brown adipocyte stem cell in the stromal vascular compartment. The absence of an accumulation of mitochondria (unpublished observations, X.X. Koza and L.P. Kozak) indicates that expression of Ucp is not sufficient to stimulate mitochondriogenesis, a conclusion reached independently from our analysis of brown adipocyte cell lines (27) . Since the aP2 gene is one of the late stage markers of adipocyte differentiation program (28) , it is possible that the adipocyte derivatives originate from white preadipocytes. However, it is unclear why they do not accumulate lipid to the extent that they form lipid vesicles. Another consideration concerning the origins of this cell type particularly in the peritoneal fat depots is its increase in number with age in normal C57BL/6J mice. Furthermore, the number of these cells increases dramatically in A ' obese mice. Is this cell an adipocyte that is generated during the aging of the animal, and is proliferating at a higher rate in animals which are susceptible to obesity? Since it is known that the proliferation of adipocytes increases in obese animals (29) the adipocyte derivatives in the transgenic mice may be those which arise in an adult animal when it becomes obese. Accordingly, the mechanisms for enhanced cell proliferation are still occurring in the A" transgenic mice but the lack of excess fat for storage results in truncated differentiation. If these speculations are correct, the cells in the fat pad would reflect the obesity related proliferative capacity of the animal's preadipocyte pool. Studies in progress with a high fat diet induced obesity in C57/BL6J mice support such an interpretation.
